Skip to Main content Skip to Navigation
Poster communications

Necker-Pasteur Clinical Metagenomics: Part 2. Contribution to Pathogen Discovery

Abstract : Clinical metagenomics fuels pathogen discovery but a comprehensive research environment is required to address critical questions such as imputability, physiopathology of novel identified infectious agents, and development of new diagnostic tools. The Institut Pasteur, in close collaboration with specialized hospital clinical services and laboratories including (neuro)pathologists, along with other academic labs, seeks to address these topics. We review some of the major identifications done in the course of our historical partnership with hospitals, by highlighting the place and the contribution of research works following identification of new or unexpected microorganisms. The list includes novel human pathogens with a zoonotic potential (Astrovirus VA1, Umbre orthobunyavirus, European Bat Lyssavirus 1) and known pathogens with unexpected or atypical presentation (Rubella virus, Rabies, Dengue).
Complete list of metadata
Contributor : Philippe Pérot Connect in order to contact the contributor
Submitted on : Monday, December 6, 2021 - 1:39:36 PM
Last modification on : Friday, August 5, 2022 - 12:02:57 PM
Long-term archiving on: : Monday, March 7, 2022 - 6:53:12 PM


Files produced by the author(s)


Distributed under a Creative Commons Attribution - NoDerivatives 4.0 International License


  • HAL Id : pasteur-03467165, version 1


Philippe Pérot, Béatrice Regnault, Franck Bielle, Jacques Fourgeaud, Éric Troadec, et al.. Necker-Pasteur Clinical Metagenomics: Part 2. Contribution to Pathogen Discovery. 6th International Conference on Clinical Metagenomics, Oct 2021, Geneva, Switzerland. ⟨pasteur-03467165⟩



Record views


Files downloads